Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats.

Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats. Abstract Text:

Mercedes Fernandez,Marc Mejias,Ester Garcia-Pras,Raul Mendez,Juan Carlos Garcia-Pagan,Jaime Bosch,

Vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF) pathways are crucial to angiogenesis, a process that contributes significantly to the pathogenesis of portal hypertension. This study determined the effects of inhibition of VEGF and/or PDGF signaling on hyperdynamic splanchnic circulation and portosystemic collateralization in rats with completely established portal hypertension, thus mimicking the situation in patients. Portal vein-ligated rats were treated with rapamycin (VEGF signaling inhibitor), Gleevec (PDGF signaling inhibitor), or both simultaneously when portal hypertension was already fully developed. Hemodynamic studies were performed by transit-time flowmetry. The extent of portosystemic collaterals was measured by radioactive microspheres. The expression of angiogenesis mediators was determined by Western blotting and immunohistochemistry. Combined inhibition of VEGF and PDGF signaling significantly reduced splanchnic neovascularization (i.e., CD31 and VEGFR-2 expression) and pericyte coverage of neovessels (that is, alpha-smooth muscle actin and PDGFR-beta expression) and translated into hemodynamic effects as marked as a 40% decrease in portal pressure, a 30% decrease in superior mesenteric artery blood flow, and a 63% increase in superior mesenteric artery resistance, yielding a significant reversal of the hemodynamic changes provoked by portal hypertension in rats. Portosystemic collateralization was reduced as well. CONCLUSIONS: Our results provide new insights into how angiogenesis regulates portal hypertension by demonstrating that the maintenance of increased portal pressure, hyperkinetic circulation, splanchnic neovascularization, and portosystemic collateralization is regulated by VEGF and PDGF in portal hypertensive rats. Importantly, these findings also suggest that an extended antiangiogenic strategy (that is, targeting VEGF/endothelium and PDGF/pericytes) may be a novel approach to the treatment of portal hypertension.

Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats. Publishing Authors By Initials

M Fernandez,M Mejias,E Garcia-Pras,R Mendez,JC Garcia-Pagan,J Bosch,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: Hepatology (Baltimore, Md.)

VOLUME: 46

Page Numbers: 1208-17

Journal Abbreviation: Hepatology

ISSN: 0270-9139

DAY: 30

MONTH: Oct

YEAR: 2007

Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8302946

Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats.

AFFILIATION: Hepatic Hemodynamic Laboratory, Liver Unit, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Hospital Clinic, Ciberehd, Universitat de Barcelona, Barcelona, Spain. mercefernandez@ub.edu

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Hepatology

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats Related Publications

• Author's Reply.
• Automated tracking of the mitral valve annulus motion in apical echocardiographic images using multidimensional dynamic programming.
• Blood volume studies in postoperative liver death.
• Cell type complexity in the basal metazoan Hydra is maintained by both stem cell based mechanisms and transdifferentiation.
• Discovering innate immunity genes using differential display: a story of RNA helicases.
• Durability, negative impact, and neuropsychological predictors of tic suppression in children with chronic tic disorder.
• Effect of verapamil on tachycardia-induced early cellular electrical remodeling in rabbit atrium.
• Elevated levels of soluble ST2 protein in dengue virus infected patients.
• Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
• Heterozygosity for the classical galactosemia mutation does not affect ovarian reserve and menopausal age.
• High incidence of hypermethioninaemia in a single neonatal intensive care unit detected by a newly introduced neonatal screening programme.
• Independent design and conduct of clinical trials.
• Induction of histone H1.2 cytosolic release in chronic lymphocytic leukemia cells after genotoxic and non-genotoxic treatment.
• Infant mortality among twins and triplets in rural Bangladesh in 1975-2002.
• Localized shape variations for classifying wall motion in echocardiograms.
• Optimized protocol for the large scale production of HIV pseudovirions by transient transfection of HEK293T cells with linear fully deacylated polyethylenimine.
• Portugal's science plots its future.
• Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats.
• Signatures of Selection in the Human Olfactory Receptor OR5I1 Gene.
• TRAIL is a novel antiviral protein against dengue virus.
• The evolution of immunity: a low-life perspective.
• Transgenic stem cells in Hydra reveal an early evolutionary origin for key elements controlling self-renewal and differentiation.
• Vascular deterioration in cirrhosis: the big picture.
• [Advances in cervical cancer prevention: HPV vaccines]
• [Development of an oxygen-laughing-gas multipurpose apparatus for obstetrical use.]
• [Function of the public health worker in health education.]
• [Is brown adipose tissue a store of long chain polyunsaturated fatty acids during postnatal developing brain?]
• [Not Available.]
• [Notes on the teaching of hygiene to students of medicine.]
• [Training of sanitation personnel in the field of public health education.]